Skip to main content
    Q

    QuidelOrtho Corp (QDEL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.21
    -0.53 (-4.93%)

    Market Cap: $736.90M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    QuidelOrtho Corp (QDEL) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2026. Financial statements from company filings, amounts in US dollars.

    QuidelOrtho reported revenue of $2.73B for the fiscal year ended Dec 31, 2025, down 1.9% from the year before. That year, net income was -$1.13B with a net margin of -41.5%, operating cash flow was $105.20M and free cash flow was -$83.00M. The quarter ended Sep 30, 2026 had revenue of $618.90M and net income of -$53.80M.

    Revenue and Margins

    The operating margin was -33.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $191.60M, a compound annual rate of 34.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.73B-1.9%46.7%-33.7%-41.5%
    Dec 2024$2.78B-7.2%46.2%-70.5%-73.7%
    Dec 2023$3.00B-8.2%49.9%4.6%-0.3%
    Dec 2022$3.27B+92.3%59.3%25.8%16.8%
    Dec 2021$1.70B+2.2%75.3%53.3%41.5%
    Dec 2020$1.66B+210.7%81.2%63.8%48.8%
    Dec 2019$534.89M+2.4%60.0%17.3%13.6%
    Dec 2018$522.28M+88.0%60.4%18.4%14.2%
    Dec 2017$277.74M+45.0%56.2%3.4%-2.9%
    Dec 2016$191.60MN/A61.7%-2.3%-7.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$2.73B$2.78B$3.00B$3.27B$1.70B$1.66B$534.89M$522.28M$277.74M$191.60M
    Cost of revenue$1.46B$1.50B$1.50B$1.33B$420.30M$312.81M$214.09M$206.57M$121.60M$73.41M
    Gross profit$1.27B$1.29B$1.50B$1.94B$1.28B$1.35B$320.81M$315.71M$156.14M$118.19M
    Research and development$186.20M$218.70M$246.80M$187.90M$95.70M$84.29M$52.55M$51.65M$33.64M$38.67M
    Operating income-$919.20M-$1.96B$139.10M$843.70M$906.00M$1.06B$92.72M$95.93M$9.55M-$4.44M
    Net income-$1.13B-$2.05B-$10.10M$548.70M$704.20M$810.29M$72.92M$74.18M-$8.16M-$13.81M
    EBITDA-$488.10M-$1.49B$607.00M$1.09B$953.30M$1.10B$139.79M$133.93M$40.31M$18.78M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$618.90M$630.90M$619.80M$723.60M$699.90M$613.90M$692.80M$707.80M$727.10M$637.00M$711.00M$742.60M
    Gross profit$289.60M$272.90M$263.80M$320.40M$335.60M$274.90M$343.30M$326.10M$352.30M$276.00M$332.10M$381.30M
    Operating income-$7.50M-$21.80M-$27.40M-$66.30M-$704.80M-$180.70M$32.60M-$100.40M$15.00M-$117.50M-$1.76B$40.10M
    Net income-$53.80M-$92.90M-$91.80M-$130.70M-$733.00M-$255.40M-$12.70M-$178.40M-$19.90M-$147.70M-$1.71B$7.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.68B exceeded cash and equivalents by $2.51B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$5.77B$6.42B$8.56B$8.86B$2.43B$1.87B$910.87M$806.37M$935.25M$388.25M
    Current assets$1.45B$1.22B$1.31B$1.58B$1.44B$1.14B$222.23M$193.40M$331.23M$225.39M
    Cash and equivalents$169.80M$98.30M$118.90M$292.90M$802.80M$489.94M$52.77M$43.70M$36.09M$169.51M
    Total liabilities$3.85B$3.44B$3.56B$3.92B$501.00M$538.46M$351.05M$380.79M$708.15M$187.62M
    Short-term debt$207.60M$372.90M$166.50M$231.90M$10.30M$7.80M$19.07M$54.38M$20.18M$98.00K
    Long-term debt$2.47B$2.14B$2.27B$2.43B$400.00KN/AN/A$53.19M$377.26M$144.34M
    Shareholder equity$1.92B$2.98B$5.01B$4.93B$1.93B$1.33B$559.82M$425.58M$227.10M$200.63M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.78B$5.72B$5.63B$5.77B$5.68B$6.38B$6.46B$6.42B$6.80B$6.69B$6.70B$8.56B
    Total liabilities$3.99B$3.94B$3.78B$3.85B$3.64B$3.59B$3.46B$3.44B$3.61B$3.52B$3.40B$3.56B
    Cash and equivalents$166.40M$123.40M$140.40M$169.80M$98.10M$151.70M$127.10M$98.30M$143.70M$107.00M$78.50M$118.90M
    Shareholder equity$1.79B$1.77B$1.85B$1.92B$2.04B$2.79B$3.00B$2.98B$3.19B$3.17B$3.31B$5.01B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$105.20M$83.00M$280.20M$885.30M$805.87M$629.76M$134.49M$136.34M$27.71M$11.81M
    Capital expenditures$188.20M$195.10M$209.30M$140.90M$292.72M$64.93M$27.23M$31.69M$17.51M$11.91M
    Free cash flow-$83.00M-$112.10M$70.90M$744.40M$513.14M$564.84M$107.26M$104.66M$10.20M-$94.00K
    Dividends paidN/AN/AN/AN/AN/AN/AN/AN/A$255.00M$0
    Investing cash flow-$192.70M-$149.90M-$187.60M-$1.64B-$319.53M-$63.32M-$27.23M$114.95M-$431.76M-$16.97M
    Financing cash flow$155.80M$48.80M-$265.80M$252.00M-$173.18M-$130.28M-$98.28M-$244.06M$270.61M-$16.80M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$19.60M-$110.60M-$33.00M$131.90M-$45.50M-$46.80M$65.60M$63.70M$117.90M-$97.90M-$700.00K$80.40M
    Capital expenditures$21.00M$25.50M$34.00M$45.30M$49.20M$6.50M$10.10M$47.20M$46.50M$35.30M$66.10M$48.60M
    Free cash flow-$1.40M-$136.10M-$67.00M$86.60M-$94.70M-$53.30M$55.50M$16.50M$71.40M-$133.20M-$66.80M$31.80M
    Last 12 quarters

    Frequently Asked Questions About QDEL

    What is QuidelOrtho's annual revenue?

    QuidelOrtho reported revenue of $2.73B for the fiscal year ended Dec 31, 2025.

    How fast is QuidelOrtho's revenue growing?

    Revenue was down 1.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -5.8%.

    Is QuidelOrtho profitable?

    No. QuidelOrtho reported net income of -$1.13B for the fiscal year ended Dec 31, 2025, with a net margin of -41.5%.

    How much free cash flow does QDEL generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $105.20M minus capital expenditures of $188.20M produced free cash flow of -$83.00M.

    How much debt does QuidelOrtho have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $2.47B, short-term debt of $207.60M and cash and equivalents of $169.80M.